Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report

INTRODUCTION: Hairy cell leukemia variant (HCL-v) is a rare lymphoproliferative disorder regarded as a splenic B-cell lymphoma/leukemia, unclassifiable tumor in the 2017 World Health Organization classification of lymphoid tumors. The prognosis of HCL-v is much worse than that of classical hairy cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Imoto, Naoto, Koyama, Daisuke, Sugiura, Isamu, Kurahashi, Shingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870251/
https://www.ncbi.nlm.nih.gov/pubmed/33592897
http://dx.doi.org/10.1097/MD.0000000000024457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870251/
https://www.ncbi.nlm.nih.gov/pubmed/33592897
http://dx.doi.org/10.1097/MD.0000000000024457

Ejemplares similares